Infinimmune Raises $12-Million Seed Funding to Design Drugs Using Human-Sourced Antibodies

Retrieved on: 2022-12-06 19:46:41

Tags for this article:

Click the tags to see associated articles and topics

Infinimmune Raises $12-Million Seed Funding to Design Drugs Using Human-Sourced Antibodies. View article details on hiswai:

Excerpt

Early-stage biotechnology company Infinimmune, which is developing ... antibodies from your human immune system or mine to other patients for a ...

Article found on: www.genengnews.com